Elanco Animal Health (ELAN) Cash from Operations (2017 - 2026)

Elanco Animal Health has disclosed Cash from Operations across 10 years of filings, most recently posting $277.0 million for Q2 2026.

• In Q2 2026, Cash from Operations rose 16.88% year-over-year to $277.0 million; the TTM figure through Jun 2026 stood at $617.0 million (up 7.87% YoY), while the FY2025 annual figure was $560.0 million, up 3.51% from the prior year.
• Cash from Operations came in at $277.0 million for Q2 2026 at Elanco Animal Health, up from $13.0 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $312.0 million in Q2 2022 to a low of -$145.0 million in Q1 2023.
• Average Cash from Operations over 5 years is $117.4 million, with a median of $159.5 million recorded in 2023.
• Year-over-year, Cash from Operations slumped 381.82% in 2022 and jumped 1107.69% in 2023.
• Over 5 years, Cash from Operations stood at $13.0 million in 2022, then jumped by 1107.69% to $157.0 million in 2023, then climbed by 12.74% to $177.0 million in 2024, then tumbled by 38.98% to $108.0 million in 2025, then jumped by 156.48% to $277.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were $277.0 million in Q2 2026, $13.0 million in Q1 2026, and $108.0 million in Q4 2025.